Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.
Cheng LL, Guan WJ, Duan CY, Zhang NF, Lei CL, Hu Y, Chen AL, Li SY, Zhuo C, Deng XL, Cheng FJ, Gao Y, Zhang JH, Xie JX, Peng H, Li YX, Wu XX, Liu W, Peng H, Wang J, Xiao GM, Chen PY, Wang CY, Yang ZF, Zhao JC, Zhong NS.
Cheng LL, et al. Among authors: liu w.
JAMA Intern Med. 2021 Jan 1;181(1):71-78. doi: 10.1001/jamainternmed.2020.5503.
JAMA Intern Med. 2021.
PMID: 32910179
Free PMC article.
Clinical Trial.